In addition to complementing chemotherapy regimens, it is possible that targeted agents could enhance the therapeutic efficacy of radiation therapy as VEGF levels and tumour cell EGFR expression have been shown to increase following exposure to ionising radiation (Akimoto et al, 1999; Dent et al, 1999; Gorski et al, 1999). The gene discussed is VEGFA; the disease is neoplasm.